Physician Assistant in Mint Hill, NC Accepting Medicare
9 Physician Assistant nurses found. Showing 1 - 9
 Dylan Malloy, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 11300 Cresthill Dr Ste 120, Mint Hill, NC 28227 Phone: 704-438-9479 Fax: 704-438-9478 |
 Kiran Deep Semelsberger, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 11304 Hawthorne Dr, Ste 100, Mint Hill, NC 28227 Phone: 704-545-6400 |
Kristen Jones, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 9150 Morgan Glenn Dr, Mint Hill, NC 28227 Phone: 614-806-3474 |
Melissa A Vanausdoll, PAC Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 7110 Lawyers Rd, Mint Hill, NC 28227 Phone: 704-537-0020 Fax: 704-537-2144 |
Sharyce Nicole Banks, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 11300 Cresthill Dr Ste 120, Mint Hill, NC 28227 Phone: 704-438-9479 |
Rosemary Grullon, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 11304 Hawthorne Dr, Suite 100, Mint Hill, NC 28227 Phone: 704-545-6400 |
Amber Sisenstein, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 11304 Hawthorne Dr, Ste 100, Mint Hill, NC 28227 Phone: 704-545-6400 |
Hanh Le, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 7707 Monogramm Ln, Mint Hill, NC 28227 Phone: 980-242-0459 |
Jennifer L. Haugen, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 11304 Hawthorne Dr, Ste 100, Mint Hill, NC 28227 Phone: 704-545-6400 |
News Archive
EMA approves Shire's new REPLAGAL manufacturing facility in Lexington
Shire plc, the global specialty biopharmaceutical company, today announced that the European Medicines Agency has approved the purification of REPLAGAL® (agalsidase alfa) drug substance at its new manufacturing facility in Lexington, MA, US. REPLAGAL, Shire's enzyme replacement therapy for the treatment of Fabry disease is the first product that will be made available to patients from the new facility.
Unexpected toxicity of pazopanib/pemetrexed in NSCLC halts study
A phase II study comparing first-line combination pazopanib/pemetrexed chemotherapy with the standard cisplatin/pemetrexed treatment in non-small-cell lung cancer was terminated early owing to an increased frequency of adverse events in the experimental arm.
Ultrasensitive biosensing method could shorten the time for identification of COVID-19
Mechanical engineering associate professor Jiangtao Cheng and electrical and computer engineering assistant professor Wei Zhou have developed an ultrasensitive biosensing method that could dramatically shorten the amount of time required to verify the presence of the COVID-19 virus in a sample.
New system accurately and reliably captures patient experience with cancer drug side effects
In cancer clinical trials, symptom side effects patients experience, like nausea, are typically reported by doctors, and not directly by patients. Previous research has shown that doctors under-report these symptoms.
ACIP recommends changes in 2012 Recommended Adult Immunization Schedule
The CDC's Advisory Committee on Immunization Practices now recommends routine HPV vaccination for males aged 11 to 12 years and catch-up vaccination for males aged 13 to 21. These are just two of the changes to the 2012 Recommended Adult Immunization Schedule being published February 1 in Annals of Internal Medicine, the flagship journal of the American College of Physicians.
› Verified 8 days ago